Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society

[Preface] In 2005, intravenous (IV) thrombolysis using alteplase, a recombinant tissue, type plasminogen activator (rt-PA), for patients with acute ischemic stroke was approved in Japanon the basis of the results of the Japan Alteplase Clinical Trial (J-ACT) with a specific low-dose regimen. Over th...

Full description

Saved in:
Bibliographic Details
Published inNeurologia medico-chirurgica Vol. 59; no. 12; pp. 449 - 491
Main Authors TOYODA, Kazunori, KOGA, Masatoshi, IGUCHI, Yasuyuki, ITABASHI, Ryo, INOUE, Manabu, OKADA, Yasushi, OGASAWARA, Kuniaki, TSUJINO, Akira, HASEGAWA, Yasuhiro, HATANO, Taketo, YAMAGAMI, Hiroshi, IWAMA, Toru, SHIOKAWA, Yoshiaki, TERAYAMA, Yasuo, MINEMATSU, Kazuo
Format Journal Article
LanguageEnglish
Published Japan The Japan Neurosurgical Society 2019
THE JAPAN NEUROSURGICAL SOCIETY
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Preface] In 2005, intravenous (IV) thrombolysis using alteplase, a recombinant tissue, type plasminogen activator (rt-PA), for patients with acute ischemic stroke was approved in Japanon the basis of the results of the Japan Alteplase Clinical Trial (J-ACT) with a specific low-dose regimen. Over the 10 years after approval, intravenous thrombolysis has become common as standard therapy for acute ischemic stroke. During this period, the Japan Stroke Society published the Guldlines forIntravenous Application of rt-PA (Alteplese) in 2005, independently of the Japanese Guidelines fpr the Management of Stroke in an effort to promote safe, widespread use of intravenous thrombolysis, and revised the present guidelines repeatedly according to subsequent accumulated evidence and changing therapeutic attitudes, The Japan Stroke Society also orgallized training sessions for proper use using the treatment guidelines as the textbook all over Japan every year and conducted a widespread awareness campaign. This effort was unique in Japan but was highly assessed outside Japan. Since 2018, e-learning has made it easier to participate in these training sessions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
This article is an English translation of the Japanese guidelines published on Japanese Journal of Stroke (41: 205–247, 2019)
The Working Group on Revised Guidelines for Intravenous Thrombolysis, Committee for Medical Improvement and Social Insurance, Japan Stroke Society
ISSN:0470-8105
1349-8029
DOI:10.2176/nmc.st.2019-0177